France

Long term, extension study of the safety and efficacy of AVP-786 for the treatment of agitation in patients with dementia of the Alzheimer's type

A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-design study to assess the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for the treatment of agitation in patients with dementia of the Alzheimer’s type

Safety and immunogenicity of repeated doses of ABvac40 in patients with amnestic mild cognitive impairment or very mild Alzheimer's disease

A Phase 3, multicenter, randomised, double-blind, placebo-controlled study of the efficacy, safety and biomarker effects of ALZ-801 in subjects with early Alzheimer's disease and APOE4/4 genotype

A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease

Effect of caffeine on cognition in Alzheimer's disease

Donepezil versus non-drug treatment in Alzheimer's disease

A study to confirm safety and efficacy of BAN2401 in participants with early Alzheimer's disease

A study to evaluate safety and tolerability of aducanumab in participants with Alzheimer's disease who had previously participated in the aducanumab studies 221AD103, 221AD301, 221AD302 and 221AD205

evoke - A research study investigating Semaglutide in people with early Alzheimer's disease

evoke+ - A research study investigating Semaglutide in people with early Alzheimer's disease

A study to evaluate the safety, tolerability, and efficacy of long-term Gantenerumab administration in participants with Alzheimer's disease (AD)

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease

A study to evaluate the pharmacodynamic effects of once weekly administration of Gantenerumab in participants with early Alzheimer's disease

Therapeutic evaluation of low-dose IL-2-based immunomodulatory approach in patients with early Alzheimer's disease

A Phase 3 study to evaluate efficacy and safety of AL001 in frontotemporal dementia

A Phase 2 study to evaluate efficacy and safety of AL002 in rarticipants with early Alzheimer's disease

A Study of Semorinemab in patients with moderate Alzheimer's disease

Prevention of cognitive decline in older adults with low Dha/Epa index in red blood cells

Safety and efficacy of TRx0237 in subjects with Alzheimer's disease followed by open-label treatment

A prospective, multicenter, with a first randomised, placebo-controlled, parallel-group, double-blind period followed by an open-label trial period to evaluate the clinical safety and efficacy of NanoLithium® NP03 in patients with mild-to-severe Alzheimer’s disease: a proof-of-concept study

A study to test the efficacy, safety, and tolerability of bepranemab in patients with mild cognitive impairment or mild Alzheimer's disease

A Phase 2a study of TPN-101 in patients with C9ORF72 ALS/FTD